Investor Presentation H1 2023

126 Investor presentation First six months of 2023 Diabetes market share and market growth in Region China 40% Diabetes market growth and Novo Nordisk market share 30% 20% 10% 32% DKK billion 40% 20% 0% 10% Diabetes market size and growth -10% 28 1 -1 ~13% Region China 25 -2 33% 32% -13% 0% -20% May 2020 -NN market share May May NN Company A Others May -Market growth (right axis) NN growth (right axis) 2023 2022 2023 Novo Nordisk Competitors Source: IQVIA, May 2023, Value, MAT; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. NN: Novo Nordisk Region China covers Mainland China, Taiwan, and Hong Kong

View entire presentation